SCHEMBL20069030

SCHEMBL20069030

CSN1CC2CC(C1)C2C(=O)Nc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.48
KMT2A Q03164 4/20 0.45
LMNA P02545 3/20 0.44
MAPT P10636 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 3/20 0.43
ALDH1A1 P00352 2/20 0.42
HPGD P15428 3/20 0.42
GRIN2B Q13224 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PKM P14618 1/20 0.41
GAA P10253 1/20 0.41
GFER P55789 1/20 0.41
MC4R P32245 1/20 0.40
GLA P06280 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ME3 Q16798 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20148028 0.84 POLB (0.51) POLBKMT2ALMNAMAPTL3MBTL1
SCHEMBL25505311 0.81 POLB (0.51) POLBKMT2ALMNAMAPTL3MBTL1
SCHEMBL20068839 0.80 ALDH1A1 (0.49) POLBKMT2ALMNAMAPTL3MBTL1
SCHEMBL25505300 0.80 POLB (0.48) POLBKMT2ALMNAMAPTL3MBTL1
SCHEMBL24515851 0.69 LMNA (0.57) POLBKMT2ALMNAMAPTL3MBTL1
SCHEMBL25641853 0.69 LMNA (0.57) POLBKMT2ALMNAMAPTL3MBTL1
SCHEMBL24515840 0.69 LMNA (0.57) POLBKMT2ALMNAMAPTL3MBTL1
SCHEMBL29215851 0.68 POLB (0.58) POLBKMT2AMAPTNPC1RAB9A
SCHEMBL30268809 0.68 POLB (0.58) POLBKMT2AMAPTNPC1RAB9A
SCHEMBL11861632 0.68 POLB (0.61) POLBKMT2ALMNAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018071454-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed